Phentermine and topiramate

Teva Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 5, 2026
Approval ID: 918df93d-e033-4419-adcc-e21655ef8158
Products: 4 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE CAPSULES . PHENTERMINE and TOPIRAMATE extended-release capsules, for oral use, CIV Initial U.S. Approval: 2012

Quick Stats

Total Products4

Labelers2

Label Sections40

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.